 BOTHELL, Wash., July 25, 2022 GLOBE NEWSWIRE -- Athira Pharma, Inc. NASDAQ: ATHA, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the details of its participation at the Alzheimers Association International Conference AAIC 2022 being held in San Diego, Calif. and virtually from July 31 August 4, 2022. 